NY 1115 Temporary Extension CMS Letter

  • Letter is also available in Portable Document Format (PDF)
DEPARTMENT OF HEALTH & HUMAN SERVICES
Centers for Medicare & Medicaid Services
7500 Security Boulevard, Mail Stop S2–01–16
Baltimore, Maryland 21244–1850
State Demonstrations Group

March 18, 2021

Donna Frescatore
State Medicaid Director
Office of Health Insurance Programs
New York State Department of Health
Empire State Plaza
Corning Tower (OCP - l21l)
Albany, NY 12237

Dear Ms. Frescatore:

Thank you for your request to extend New York´s section 1115(a) demonstration, titled "Medicaid Redesign Team" (MRT) (Project Number 11-W-00114/2). The Centers for Medicare & Medicaid Services (CMS) received New York´s extension proposal on March 5, 2021. We have completed a preliminary review of your request and have determined that the state´s submission meets the requirements for a complete extension application in accordance with 42 CFR 431.412(c).

New York´s extension application will be posted on Medicaid.gov and the comment period will last 30 days in accordance with 42 CFR 431.416(b). The state´s application will be available here.

In addition, this letter also serves to inform the state that, while CMS and New York work in partnership on the extension proposal, CMS is approving a temporary extension of the MRT demonstration through March 31, 2022. The current Special Terms and Conditions (STCs), waivers, and expenditure authorities will continue to apply during the temporary extension period, including the state´s current budget neutrality per member per month (PMPM) limits for demonstration year 23. As detailed in State Medicaid Director Letter #18-009, dated August 22, 2018, CMS expects to rebase all demonstration extensions that begin on or after January 1, 2021. Therefore, CMS will work during the temporary extension period with New York to rebase it.

For the temporary extension period, the state should continue to monitor its demonstration as stipulated in the current STCs. The state should also include the temporary extension period in its evaluation design for the next extension period, once approved. In the event that the state does not obtain an extension of MRT, it should provide an assessment detailing how it met the demonstration´s goals in its final report, as described in Section VIII, STC #8.

Your CMS project officer for this demonstration is Mr. Jonathan Morancy. Mr. Morancy is available to answer any questions concerning your section 1115(a) demonstration and can be reached at Jonathan.Morancy@cms.hhs.gov.

If you have questions regarding this communication, please contact me at (410) 786-9686.

Sincerely,

Teresa DeCaro, RN, M.S.
Acting Director

cc: Michael Kahnowitz, State Monitoring Lead, Medicaid and CHIP Operations Group